The mu/delta opioid dual agonist SRI22141 demonstrates increased anti-nociceptive efficacy with decreased tolerance and dependence in neuropathic pain models

Wei Lei, R. Vekariya, S. Ananthan, J. M. Streicher

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalJournal of Pain
StatePublished - 2019

Cite this